Corbus Pharmaceuticals Holdings Income Statement (2013-2025) | CRBP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.65M	0.14M	0.10M
Operating items
Research & Development (Quarter)	10.72M	11.27M	8.70M	0.38M	3.29M	2.50M	4.11M	6.24M	13.39M	4.25M	6.55M	6.98M	5.76M	6.87M	10.81M	8.79M	15.64M	15.19M	20.86M
Selling, General & Administrative (Quarter)	5.34M	5.57M	5.28M	0.23M	5.23M	4.84M	4.07M	4.55M	3.91M	3.94M	2.94M	3.12M	3.86M	4.12M	4.70M	3.82M	4.13M	3.96M	3.56M
Restructuring Costs (Quarter)						5.00M
Other Operating Expenses (Quarter)				9.39M
Operating Expenses (Quarter)	16.06M	16.84M	13.97M	10.00M	8.52M	12.34M	8.18M	10.80M	17.30M	8.19M	9.49M	10.10M	9.62M	10.99M	15.51M	12.61M	19.77M	19.15M	24.42M
Operating Income (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-8.19M	-9.49M	-10.10M	1.03M	1.60M	1.90M	1.78M	-19.77M	-19.15M	1.12M
EBIT (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-8.19M	-9.49M	-10.10M	1.03M	1.60M	1.90M	1.78M	-19.77M	-19.15M	1.12M
Non-operating items
Non Operating Investment Income (Quarter)					-0.11M	0.05M	-0.09M	0.08M	0.06M	0.04M	0.02M	0.01M	-0.33M				-0.06M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.02M	-0.01M	0.47M	12.31M	-0.19M	-0.21M	0.08M	0.19M	728.00	0.18M		2.07M	2.54M	0.04M	0.20M	1.29M	1.12M	0.18M	-0.05M
Non Operating Income (Quarter)	-0.02M	-0.44M	12.03M	0.32M	-0.92M	-0.21M	0.08M	2.38M	-0.45M	0.18M	0.22M	-0.16M	2.54M	0.04M	1.72M	-1.36M	1.12M	0.18M	-0.05M
Net income details
EBT (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-9.19M	-10.47M	-11.03M	0.19M	0.95M	1.52M	1.78M	-19.77M	-19.15M	1.12M
Profit After Tax (Quarter)	-16.07M	-17.14M	-2.18M	-10.26M	-9.44M	-13.25M	-8.78M	-10.88M	-17.74M	-8.78M	-10.05M	-8.02M	-6.90M	-10.00M	-13.78M	-9.53M	-16.98M	-17.66M	-23.34M
Income from Continuing Operations (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-9.19M	-10.47M	-11.03M	0.19M	0.95M	1.52M	1.78M	-19.77M	-19.15M	1.12M
Consolidated Net Income (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-9.19M	-10.47M	-11.03M	0.19M	0.95M	1.52M	1.78M	-19.77M	-19.15M	1.12M
Income towards Parent Company (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-9.19M	-10.47M	-11.03M	0.19M	0.95M	1.52M	1.78M	-19.77M	-19.15M	1.12M
Net Income towards Common Stockholders (Quarter)	-15.41M	-16.70M	-13.88M	-10.00M	-8.52M	-12.34M	-8.18M	-10.80M	-17.30M	-9.19M	-10.47M	-11.03M	0.19M	0.95M	1.52M	1.78M	-19.77M	-19.15M	1.12M
Additional items
EPS (Basic) (Quarter)	-0.14	-0.15	-0.02	-10.86	-2.26	-3.18	-2.11	-2.60	-4.24	-2.05	-2.27	-1.79	-0.83	-0.90	-1.15	-0.76	-1.39	-1.44	-1.90
EPS (Weighted Average and Diluted) (Quarter)			-0.02	-10.86	-2.26	-3.18	-2.11	-2.60	-4.24	-2.05	-2.27	-1.79	-0.83	-0.90	-1.15	-0.76	-1.39	-1.44	-1.90
Shares Outstanding (Weighted Average) (Quarter)	116.34M	120.72M	122.23M	4.09M	4.17M	4.17M	4.17M	4.17M	4.18M	4.28M	4.42M	4.33M	8.31M	11.05M	10.49M	10.92M	12.20M	12.24M	12.31M	17.61M
Shares Outstanding (Diluted Average) (Quarter)			122.23M	4.09M	4.17M	4.17M	4.17M	4.17M	4.18M	4.28M	4.42M	4.33M	8.31M	9.68M	12.01M	10.92M	12.20M	12.22M	12.31M
EBITDA (Quarter)	-16.09M	-17.12M	-2.18M	-10.00M	-9.54M	-13.20M	-8.87M	-10.80M	-17.69M	-8.74M	-10.04M	-8.01M	-7.23M	1.60M	1.90M	1.78M	-17.04M	-19.15M	1.12M
Interest Expenses (Quarter)										1.00M	0.98M	0.93M	0.84M	0.65M	0.38M

Research Tools

Corbus Pharmaceuticals Holdings Income Statement (2013-2025) | CRBP

Create an account

Sign In

Reset Password